SCHEMBL386032

SCHEMBL386032

FC(F)(F)C(F)(F)CCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9854322 0.80 LMNA (0.32)
SCHEMBL538153 0.78
SCHEMBL2495980 0.78 LMNA (0.36)
SCHEMBL1358665 0.76
SCHEMBL248018 0.76
SCHEMBL5556024 0.76 LMNA (0.41)
SCHEMBL9854413 0.76 LMNA (0.41)
SCHEMBL5376186 0.76 LMNA (0.41)
SCHEMBL9854284 0.71
SCHEMBL1019091 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119823047-B Fluorine-containing imidazolium salt, and preparation method and application thereof 西南石油大学 2025-05-30 CN disclosed
US-20250129077-A1 SUBSTITUTED PURINES AS TLR7 AGONISTS Primmune Therapeutics, Inc. 2025-04-24 US disclosed
CN-119823047-A Fluorine-containing imidazolium salt, and preparation method and application thereof 西南石油大学 2025-04-15 CN disclosed
EP-4512816-A2 TLR7 AGONISTS Primmune Therapeutics, Inc. (US) 2025-02-26 EP disclosed
CN-112533607-B TLR7 agonists 普利缪尼治疗学股份有限公司 2025-01-07 CN disclosed
EP-3801538-B1 TLR7 AGONISTS PRIMMUNE THERAPEUTICS INC (US) 2024-10-02 EP disclosed
US-12037335-B2 Substituted purines as TLR7 agonists Primmune Therapeutics, Inc. (US) 2024-07-16 US disclosed
US-20220098198-A1 SUBSTITUTED PURINES AS TLR7 AGONISTS Primmune Therapeutics, Inc. 2022-03-31 US disclosed
US-11059824-B2 Substituted purines as TLR7 agonists Primmune Therapeutics, Inc. (US) 2021-07-13 US disclosed
EP-3801538-A1 TLR7 AGONISTS Primmune Therapeutics, Inc. (US) 2021-04-14 EP disclosed
WO-2007053671-A1 AEROSOL PROPELLANTS COMPRISING UNSATURATED FLUOROCARBONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-05-10 WO disclosed
US-20070102021-A1 Solvent compositions comprising unsaturated fluorinated hydrocarbons THE CHEMOURS COMPANY FC, LLC 2007-05-10 US disclosed
US-20070098646-A1 Aerosol propellants comprising unsaturated fluorocarbons E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed
US-20070100011-A1 Blowing agents for forming foam comprising unsaturated fluorocarbons THE CHEMOURS COMPANY FC, LLC 2007-05-03 US disclosed
US-20070100009-A1 Methods for making foams using blowing agents comprising unsaturated fluorocarbons THE CHEMOURS COMPANY FC, LLC 2007-05-03 US disclosed
US-20070100010-A1 Blowing agents for forming foam comprising unsaturated fluorocarbons E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed
EP-1731518-A1 CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2006-12-13 EP disclosed
EP-0252736-B1 PROCESS FOR PREPARING FLUORINE-CONTAINING CARBOXYLIC ACID ESTER SAGAMI CHEMICAL RESEARCH CENTER (JP) 1991-07-24 EP disclosed
US-4855487-A Process for preparing fluorine-containing carboxylic acid ester SAGAMI CHEMICAL RESEARCH CENTER (JP) 1989-08-08 US disclosed
EP-0252736-A2 Process for preparing fluorine-containing carboxylic acid ester SAGAMI CHEMICAL RESEARCH CENTER (JP) 1988-01-13 EP disclosed